Capricor Therapeutics Inc (NASDAQ: CAPR) is -31.59% lower on its value in year-to-date trading and has touched a low of $3.52 and a high of $23.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CAPR stock was last observed hovering at around $9.56 in the last trading session, with the day’s loss setting it -0.12%.
Currently trading at $9.44, the stock is -8.72% and -13.15% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.26 million and changing -1.26% at the moment leaves the stock -24.59% off its SMA200. CAPR registered 81.54% gain for a year compared to 6-month loss of -47.85%.
The stock witnessed a -2.07% gain in the last 1 month and extending the period to 3 months gives it a -40.82%, and is 48.90% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.45% over the week and 13.72% over the month.
Capricor Therapeutics Inc (CAPR) has around 160 employees, a market worth around $431.48M and $17.36M in sales. Profit margin for the company is -317.13%. Distance from 52-week low is 168.18% and -59.66% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.90%).
with sales reaching $2.97M over the same period.The EPS is expected to grow by 57.39% this year, but quarterly earnings will post 282.79% year-over-year. Quarterly sales are estimated to shrink -25.25% in year-over-year returns.
Capricor Therapeutics Inc (CAPR) Top Institutional Holders
The shares outstanding are 45.68M, and float is at 40.15M with Short Float at 25.75%.
The top institutional shareholder in the company is BLACKROCK INC. with over 1.63 million shares valued at $7.77 million. The investor’s holdings represent 5.1145% of the CAPR Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.55 million shares valued at $7.39 million to account for 4.8645 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 0.64 million shares representing 2.0149% and valued at over $3.06 million, while MILLENNIUM MANAGEMENT LLC holds 1.5059 of the shares totaling 0.48 million with a market value of $2.29 million.
Capricor Therapeutics Inc (CAPR) Insider Activity
The most recent transaction is an insider purchase by Nippon Shinyaku Co Ltd, the company’s 10% Owner. SEC filings show that Nippon Shinyaku Co Ltd bought 2,798,507 shares of the company’s common stock on Sep 20 ’24 at a price of $5.36 per share for a total of $15.0 million. Following the purchase, the insider now owns 7.09 million shares.
